---
title: "12 Health Care Stocks Moving In Wednesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294238723.md"
description: "During Wednesday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Autonomix Medical (up 89.4%), SciSparc (up 25.89%), and MapLight Therapeutics (up 21.16%). NeoGenomics and Avantor also rose, with earnings reports cited for the latter two. Conversely, major losers featured Moleculin Biotech (down 37.2%), Processa Pharma (down 29.19%), and Apimeds Pharmaceuticals (down 28.38%)."
datetime: "2026-07-29T17:06:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294238723.md)
  - [en](https://longbridge.com/en/news/294238723.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294238723.md)
---

# 12 Health Care Stocks Moving In Wednesday's Intraday Session

### Gainers

-   **Autonomix Medical** (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's regular session. The market value of their outstanding shares is at $1.4 million.
-   **SciSparc** (NASDAQ:SPRC) shares increased by 25.89% to $6.71. The market value of their outstanding shares is at $3.0 million.
-   **MapLight Therapeutics** (NASDAQ:MPLT) shares increased by 21.16% to $14.91. The company's market cap stands at $558.2 million.
-   **NeoGenomics** (NASDAQ:NEO) shares increased by 16.3% to $15.59. The market value of their outstanding shares is at $1.7 billion. The company's, Q2 earnings came out yesterday.
-   **Avantor** (NYSE:AVTR) stock rose 13.8% to $14.13. The market value of their outstanding shares is at $8.4 billion. The company's, Q2 earnings came out today.
-   **Co-Diagnostics** (NASDAQ:CODX) stock rose 11.34% to $1.57. The company's market cap stands at $5.1 million.

### Losers

-   **Moleculin Biotech** (NASDAQ:MBRX) stock declined by 37.2% to $1.38 during Wednesday's regular session. The company's market cap stands at $11.6 million.
-   **Processa Pharma** (NASDAQ:PCSA) shares fell 29.19% to $2.16. The company's market cap stands at $8.4 million.
-   **Apimeds Pharmaceuticals** (AMEX:APUS) stock fell 28.38% to $5.73. The market value of their outstanding shares is at $12.0 million.
-   **Silexion Therapeutics** (NASDAQ:SLXN) shares declined by 27.76% to $1.77. The company's market cap stands at $2.6 million.
-   **Aspire Biopharma Holdings** (NASDAQ:ASBP) shares fell 18.02% to $5.94. The market value of their outstanding shares is at $9.3 million.
-   **AIxCrypto Hldgs** (NASDAQ:AIXC) shares fell 17.43% to $0.68. The market value of their outstanding shares is at $16.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [AVTR.US](https://longbridge.com/en/quote/AVTR.US.md)
- [MBRX.US](https://longbridge.com/en/quote/MBRX.US.md)
- [MPLT.US](https://longbridge.com/en/quote/MPLT.US.md)
- [APUS.US](https://longbridge.com/en/quote/APUS.US.md)
- [PCSA.US](https://longbridge.com/en/quote/PCSA.US.md)
- [NEO.US](https://longbridge.com/en/quote/NEO.US.md)
- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [CODX.US](https://longbridge.com/en/quote/CODX.US.md)
- [SLXN.US](https://longbridge.com/en/quote/SLXN.US.md)
- [ASBP.US](https://longbridge.com/en/quote/ASBP.US.md)
- [AIXC.US](https://longbridge.com/en/quote/AIXC.US.md)
- [SLXNW.US](https://longbridge.com/en/quote/SLXNW.US.md)
- [ASBPW.US](https://longbridge.com/en/quote/ASBPW.US.md)

## Related News & Research

- [AVTR: Q2 outperformed expectations, driving raised 2026 guidance and strong free cash flow for debt reduction](https://longbridge.com/en/news/294221083.md)
- [Avantor’s VWR Distribution Unit Faces Heightened Goodwill Impairment Risk After Share Price Decline](https://longbridge.com/en/news/294314116.md)
- [MPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law](https://longbridge.com/en/news/294649107.md)
- [SciSparc subsidiary NeuroThera Labs’ quantum platform completes end-to-end hybrid workflow for clinical data analytics](https://longbridge.com/en/news/294512483.md)
- [SciSparc targets agentic AI market as new growth strategy](https://longbridge.com/en/news/294213778.md)